HRP20100560T1 - Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina - Google Patents

Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina Download PDF

Info

Publication number
HRP20100560T1
HRP20100560T1 HR20100560T HRP20100560T HRP20100560T1 HR P20100560 T1 HRP20100560 T1 HR P20100560T1 HR 20100560 T HR20100560 T HR 20100560T HR P20100560 T HRP20100560 T HR P20100560T HR P20100560 T1 HRP20100560 T1 HR P20100560T1
Authority
HR
Croatia
Prior art keywords
use according
interest
polypeptide
human
subunit
Prior art date
Application number
HR20100560T
Other languages
English (en)
Croatian (hr)
Inventor
Chatellard Philippe
Imhof Markus
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HRP20100560T1 publication Critical patent/HRP20100560T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20100560T 2003-10-21 2010-10-14 Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina HRP20100560T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103890 2003-10-21
PCT/EP2004/052591 WO2005040384A1 (fr) 2003-10-21 2004-10-20 Sequence d'adn minime isolant la chromatine et son utilisation dans l'expression de proteine

Publications (1)

Publication Number Publication Date
HRP20100560T1 true HRP20100560T1 (hr) 2010-11-30

Family

ID=34486337

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100560T HRP20100560T1 (hr) 2003-10-21 2010-10-14 Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina

Country Status (17)

Country Link
US (1) US8133699B2 (fr)
EP (1) EP1675956B1 (fr)
JP (1) JP4745972B2 (fr)
AT (1) ATE484591T1 (fr)
AU (1) AU2004284243B2 (fr)
CA (1) CA2541523A1 (fr)
CY (1) CY1110868T1 (fr)
DE (1) DE602004029598D1 (fr)
DK (1) DK1675956T3 (fr)
ES (1) ES2354160T3 (fr)
HR (1) HRP20100560T1 (fr)
IL (1) IL175021A (fr)
NO (1) NO338767B1 (fr)
PL (1) PL1675956T3 (fr)
PT (1) PT1675956E (fr)
SI (1) SI1675956T1 (fr)
WO (1) WO2005040384A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4307079B2 (ja) 2001-01-26 2009-08-05 セレキス エスアー マトリックス付着領域およびその使用方法
DK1601776T3 (da) 2003-03-11 2008-10-13 Serono Lab Ekspressionsvektorer omfattende mCmV-IE2-promotoren
ATE549353T1 (de) * 2003-05-13 2012-03-15 Merck Serono Sa Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
RU2375450C2 (ru) 2003-10-24 2009-12-10 Селексис С.А. Днк, повышающая продуцирование белка, и ее применение
ATE360647T1 (de) * 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
SI1720979T1 (sl) 2004-03-01 2007-12-31 Ares Trading Sa Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev
DE602005009827D1 (de) * 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
PL2267024T3 (pl) * 2005-06-03 2012-10-31 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN
EP1760092A1 (fr) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. Système pour le criblage des cellules à haute expression d'une protéine d'intérêt
FR2919616A1 (fr) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon Polynucleotides insulateurs derives de l'element d4z4 et leurs utilisations en transgenese
KR101993938B1 (ko) 2011-04-13 2019-06-27 내셔날 리서치 카운실 오브 캐나다 IFNα2로부터의 SAR 인자를 갖는 발현 시스템
US20140342432A1 (en) * 2011-12-21 2014-11-20 Danisco Us Inc. Fungal Gene Expression Using Insulator DNA Sequences
JP6297559B2 (ja) * 2012-07-31 2018-03-20 バジル・エム・ハンタッシュBasil M. HANTASH Hlag改変された細胞および方法
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
WO2017075395A1 (fr) * 2015-10-28 2017-05-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vecteurs adénoviraux à spécificité tumorale et leurs utilisations thérapeutiques
CA3002524A1 (fr) * 2015-10-28 2017-05-04 Sangamo Therapeutics, Inc. Constructions specifiques au foie, cassettes d'expression du facteur viii et leurs methodes d'utilisation
CN106754817B (zh) * 2016-11-03 2021-02-05 山西省生物研究院有限公司 一种重组自分泌运动因子的表达方法
US10947295B2 (en) 2017-08-22 2021-03-16 Sanabio, Llc Heterodimers of soluble interferon receptors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
US6432700B1 (en) * 1997-03-03 2002-08-13 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
US6194152B1 (en) * 1997-08-20 2001-02-27 Dendreon Corporation Prostate tumor polynucleotide compositions and methods of detection thereof
AU1128400A (en) * 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
CA2377929A1 (fr) * 1999-06-30 2001-01-11 Adam C. Bell Sequence et proteine de liaison a l'adn utilisees en tant qu'isolants dotes d'une activite de blocage d'amplificateurs specifiques pour la regulation d'une expression genique
DK1601776T3 (da) 2003-03-11 2008-10-13 Serono Lab Ekspressionsvektorer omfattende mCmV-IE2-promotoren
ATE549353T1 (de) 2003-05-13 2012-03-15 Merck Serono Sa Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
ATE360647T1 (de) 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
SI1720979T1 (sl) 2004-03-01 2007-12-31 Ares Trading Sa Uporaba medija za celiäśno kulturo brez seruma zaizdelavo il-18bp pri celicah sesalcev
DE602005009827D1 (de) 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
PL2267024T3 (pl) 2005-06-03 2012-10-31 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN

Also Published As

Publication number Publication date
AU2004284243B2 (en) 2010-11-04
DK1675956T3 (da) 2010-11-22
ES2354160T3 (es) 2011-03-10
CA2541523A1 (fr) 2005-05-06
WO2005040384A1 (fr) 2005-05-06
ATE484591T1 (de) 2010-10-15
IL175021A0 (en) 2006-08-20
US8133699B2 (en) 2012-03-13
NO338767B1 (no) 2016-10-17
JP2007508833A (ja) 2007-04-12
EP1675956A1 (fr) 2006-07-05
SI1675956T1 (sl) 2010-12-31
US20070134761A1 (en) 2007-06-14
NO20062315L (no) 2006-07-18
DE602004029598D1 (de) 2010-11-25
PT1675956E (pt) 2010-11-04
CY1110868T1 (el) 2015-06-10
PL1675956T3 (pl) 2011-06-30
IL175021A (en) 2011-07-31
JP4745972B2 (ja) 2011-08-10
AU2004284243A1 (en) 2005-05-06
EP1675956B1 (fr) 2010-10-13

Similar Documents

Publication Publication Date Title
HRP20100560T1 (hr) Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina
CA2516157A1 (fr) Vecteurs d'expression comprenant le promoteur de mcmv ie2
Suematsu et al. IgG1 plasmacytosis in interleukin 6 transgenic mice.
ATE127518T1 (de) Mikrobisch-produziertes rinderwachstumshormon und dessen verwendung.
PL209110B1 (pl) Sposób obniżania immunogenności białka fuzyjnego, białko fuzyjne otrzymane takim sposobem, zawierająca je kompozycja farmaceutyczna i kodujący je kwas nukleinowy
Reff High-level production of recombinant immunoglobulins in mammalian cells
EA199900483A1 (ru) δ-ЭНДОТОКСИНЫ ШИРОКОГО СПЕКТРА ДЕЙСТВИЯ
Westerhof et al. 3D domain swapping causes extensive multimerisation of human interleukin-10 when expressed in planta
EP0141484A2 (fr) Procédé de préparation de séquences hybrides d'ADN et polypeptides hybrides et séquences d'ADN produites par celles-ci
ES2564227T3 (es) Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
WO2011065935A1 (fr) Procédés de production d'anticorps monoclonaux
Platis et al. High yield expression, refolding, and characterization of recombinant interferon α2/α8 hybrids in Escherichia coli
Müller et al. Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems
CN103865947A (zh) 一种包含弱化的sv40启动子/二氢叶酸还原酶表达元件的真核表达载体及其构建方法
US20090111146A1 (en) Antibody Drug
TW570977B (en) An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof
US9085627B2 (en) Expression system with SAR element from IFNα2
KR101955366B1 (ko) 인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
EP1957660B1 (fr) Matieres et methodes destinees a renforcer l'expression d'une chaine peptidique
Brewer Post-transcriptional considerations of gene expression: translation, mRNA stability, and poly (A) processing
JP2017070224A (ja) 遺伝子発現用カセット及びその産生物
KR20210081989A (ko) 동물세포 발현벡터
Yasukawa et al. Regulation of Human B Cell Differentiation: Molecular Structure and Immunological
Class et al. Patent application title: Expression System With Sar Element From IFNalpha2 Inventors: Yves Durocher (Montreal, CA) Assignees: NATIONAL RESEARCH COUNCIL OF CANADA
CA2459013A1 (fr) Proteines pouvant commander la migration cellulaire et la mort cellulaire